DONE DEAL: QPR have agreed to sign Peterborough United attacker after hijacking Glasgow Rangers’ deal, Medicals all Set…
Exclusive: Kwame Poku set for QPR medical after Glasgow Rangers deal hijacked
QPR have agreed to sign Peterborough United attacker Kwame Poku after hijacking Glasgow Rangers’ deal, sources have told Football Insider.
The 23-year-old is set for a medical at the London club as he heads in for final talks to complete the move.
Poku, 23 is out of contract at the end of the month and Scottish giants Rangers were hopeful of winning the race for the player’s signature.
But QPR have ambushed Rangers and agreed a compensation fee with Peterborough for the forward in what they regard as a big coup.
QPR ambush Rangers after agreeing Poku compensation
| Appearances (Starts) | 31 (28) |
| Minutes Played | 2364 |
| Goals | 12 |
| Assists | 11 |
| Yellow Cards | 0 |
The London-born Ghana international had been a star performer for Peterborough since joining from Colchester in 2021.
Poku notched 12 goals and 11 assists in 31 appearances across all competitions in the 2024-25 campaign, despite missing a big chunk of action with a hamstring injury.
He is now set to make the step up to the Championship and is already experienced in the second tier after experiencing relegation with Peterborough in the 2021-22 season.
The winger has already racked up more than 200 senior appearances for the Posh and Colchester, scoring 36 goals and notching 37 assists.
QPR are expected to appoint former Rennes boss Julien Stephan in the coming days after the R’s placed Marti Cifuentes on gardening leave in April.
Martin makes decision on two key Rangers exits
Meanwhile, Football Insider has revealed (17 June) that Rangers boss Russell Martin is keen to build his side around in-demand duo Hamza Igamane and Nicolas Raskin.
Both players are attracting interest in the English Premier League after their good showings for the Ibrox club in the 2024-25 campaign.
Sources say Rangers are still susceptible to big offers for the duo despite their recent US-backed takeover – but do not need to sell for below-market prices
Leave a Reply